Sam J. Lubner
Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Sam J. Lubner

Hematology Oncology | Oncology
UW Health
University Of Wisconsin Medical Foundation Inc
707 S University Ave, 
Beaver Dam, WI 
Accepting New Patients
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
UW Health
University Of Wisconsin Medical Foundation Inc
707 S University Ave, 
Beaver Dam, WI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sam Lubner is a Hematologist Oncology specialist and an Oncologist in Beaver Dam, Wisconsin. Dr. Lubner is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Colorectal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Pancreaticoduodenectomy, and Colonoscopy. Dr. Lubner is currently accepting new patients.

His clinical research consists of co-authoring 55 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Oncology
Licenses
Internal Medicine in WI
Hospital Affiliations
University Of Wi Hospitals & Clinics Authority
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Quartz
  • HMO
  • POS
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION INC
707 S University Ave, Beaver Dam, WI 53916
Call: 920-887-4105
Other Locations
UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION INC
600 Highland Ave, Madison, WI 53792
Call: 608-263-6400

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
Enrollment Status: Completed
Publish Date: January 12, 2026
Intervention Type: Drug
Study Drugs: Cisplatin, Gemcitabine, Nab-Paclitaxel
Study Phase: Phase 3
Randomized Phase II Study of Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
Randomized Phase II Study of Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas
Enrollment Status: Active_not_recruiting
Publish Date: December 29, 2025
Intervention Type: Drug, Other
Study Drugs: Capecitabine, Carboplatin, Cisplatin, Etoposide, Temozolomide
Study Phase: Phase 2
Randomized, Double-Blinded Phase III Study of CABozantinib Versus Placebo IN Patients With Advanced NEuroendocrine Tumors After Progression on Prior Therapy (CABINET)
Randomized, Double-Blinded Phase III Study of CABozantinib Versus Placebo IN Patients With Advanced NEuroendocrine Tumors After Progression on Prior Therapy (CABINET)
Enrollment Status: Active_not_recruiting
Publish Date: December 03, 2025
Intervention Type: Other, Procedure, Drug
Study Drug: Cabozantinib S-malate
Study Phase: Phase 3
A Phase II Study of Atezolizumab and Bevacizumab in Child-Pugh B7 and B8 Hepatocellular Carcinoma (The AB7 Trial)
A Phase II Study of Atezolizumab and Bevacizumab in Child-Pugh B7 and B8 Hepatocellular Carcinoma (The AB7 Trial)
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Drug
Study Drugs: Atezolizumab, Bevacizumab
Study Phase: Phase 2
An Adaptive, Open-Label, Randomized Phase 2 Study of Abemaciclib as a Monotherapy and in Combination With Other Agents Versus Choice of Standard of Care (Gemcitabine or Capecitabine) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma
An Adaptive, Open-Label, Randomized Phase 2 Study of Abemaciclib as a Monotherapy and in Combination With Other Agents Versus Choice of Standard of Care (Gemcitabine or Capecitabine) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma
Enrollment Status: Completed
Publish Date: November 20, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

55 Total Publications

MAPK Pathway Mutations Emerge in Mutant-IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the Interferon Response.
MAPK Pathway Mutations Emerge in Mutant-IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the Interferon Response.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 02, 2025
View All 55 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Cheruppolil R. Santhosh-Kumar
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Cheruppolil R. Santhosh-Kumar
Hematology Oncology | Hematology | Oncology
1222 N 23rd St, 
Sheboygan, WI 
 (58.6 miles away)
920-457-6800
Languages Spoken:
English
See accepted insurances

Cheruppolil Santhosh-Kumar is a Hematologist Oncology specialist and a Hematologist in Sheboygan, Wisconsin. Dr. Santhosh-Kumar is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and WT1-Related Wilms Tumor Syndromes.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kathryn A. Bylow
Hematology Oncology | Geriatrics | Hematology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Kathryn A. Bylow
Hematology Oncology | Geriatrics | Hematology

The Medical College Of Wisconsin Inc

8701 Watertown Plank Rd, Room 4041 Mfrc, 
Milwaukee, WI 
 (49.2 miles away)
414-805-3666
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kathryn Bylow is a Hematologist Oncology specialist and a Geriatrics provider in Milwaukee, Wisconsin. Dr. Bylow is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Liver Embolization, and Gastrostomy. Dr. Bylow is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Emily G. Robinson
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Emily G. Robinson
Hematology Oncology | Hematology | Oncology

Mercy Health System Corporation

1000 Mineral Point Ave, 
Janesville, WI 
 (53.6 miles away)
608-756-6000
Languages Spoken:
English
See accepted insurances

Emily Robinson is a Hematologist Oncology specialist and a Hematologist in Janesville, Wisconsin. Dr. Robinson is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Mantle Cell Lymphoma (MCL), Desmoplastic Small Round Cell Tumor, Paget Disease of the Breast, and Small Cell Lung Cancer (SCLC).

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lubner's expertise for a condition
ConditionClose
    • Distinguished
    • Appendix Cancer
      Dr. Lubner is
      Distinguished
      . Learn about Appendix Cancer.
      See more Appendix Cancer experts
    • Cholangiocarcinoma (Bile Duct Cancer)
      Dr. Lubner is
      Distinguished
      . Learn about Cholangiocarcinoma (Bile Duct Cancer).
      See more Cholangiocarcinoma (Bile Duct Cancer) experts
    • Colorectal Cancer
      Dr. Lubner is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Familial Colorectal Cancer
      Dr. Lubner is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Familial Pancreatic Cancer
      Dr. Lubner is
      Distinguished
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Gastroesophageal Junction Cancer
      Dr. Lubner is
      Distinguished
      . Learn about Gastroesophageal Junction Cancer.
      See more Gastroesophageal Junction Cancer experts
    View All 8 Distinguished Conditions
    • Advanced
    • Ampullary Cancer
      Dr. Lubner is
      Advanced
      . Learn about Ampullary Cancer.
      See more Ampullary Cancer experts
    • Anal Cancer
      Dr. Lubner is
      Advanced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Fibrolamellar Carcinoma
      Dr. Lubner is
      Advanced
      . Learn about Fibrolamellar Carcinoma.
      See more Fibrolamellar Carcinoma experts
    • Gastrointestinal Stromal Tumor
      Dr. Lubner is
      Advanced
      . Learn about Gastrointestinal Stromal Tumor.
      See more Gastrointestinal Stromal Tumor experts
    • Lynch Syndrome
      Dr. Lubner is
      Advanced
      . Learn about Lynch Syndrome.
      See more Lynch Syndrome experts
    • Pseudomyxoma Peritonei
      Dr. Lubner is
      Advanced
      . Learn about Pseudomyxoma Peritonei.
      See more Pseudomyxoma Peritonei experts
    View All 8 Advanced Conditions
    • Experienced
    • Adult Soft Tissue Sarcoma
      Dr. Lubner is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Agranulocytosis
      Dr. Lubner is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Chromophobe Renal Cell Carcinoma
      Dr. Lubner is
      Experienced
      . Learn about Chromophobe Renal Cell Carcinoma.
      See more Chromophobe Renal Cell Carcinoma experts
    • Clear Cell Sarcoma
      Dr. Lubner is
      Experienced
      . Learn about Clear Cell Sarcoma.
      See more Clear Cell Sarcoma experts
    • Colonoscopy
      Dr. Lubner is
      Experienced
      . Learn about Colonoscopy.
      See more Colonoscopy experts
    • Endoscopy
      Dr. Lubner is
      Experienced
      . Learn about Endoscopy.
      See more Endoscopy experts
    View All 28 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved